Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137)

Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human IgG2 monoclonal antibody targeting the T-cell costimulatory receptor 4-1BB/CD137. It can be used for the research of relapsed/refractory follicular lymphoma (FL), non-Hodgkin lymphomas (NHL). MW :142.78.
Supplier Selleck Chemicals
Product # A2620
Sku # A2620-1mg
Pricing 1mg, $370.00
Feedback